Symphony Environmental T... Share Discussion Threads

[dave4545] 01/4/2021 10:58

19.15-19.4p

profit taking did kick in so 2p off the high to buy now

[dave4545] 01/4/2021 09:51

Real shortage of shares too.

Now NT at 21p

Must come a point where the mm's get a few decent sellers to help them out but atm
it's one way traffic

[angus17] 01/4/2021 09:39

hmmmm there must be a real shortage of these stocks in the market. Didn't think we would see this anytime soon.

[dave4545] 01/4/2021 09:24

Been NT to buy at 20p for a hour

19-20p

19.5 mid price to sell.

Still looks very strong

[bbmsionlypostafter] 01/4/2021 09:03

Let me guess. Company hired by SYM finds everything SYM does tickety boo.

That about it?

[ga_dti] 01/4/2021 08:49

Watch our exclusive interview with Michael Laurier discussing the findings of a 5-year oxomar study:

[dave4545] 01/4/2021 08:17

Super strong online 18.5-19p

18.85 bid and nothing offered at 19p

[dave4545] 01/4/2021 07:50

Well it's already up pre market from 17.5 to 18p so looking like another positive start.

[laughingmike] 31/3/2021 23:12

Also some director share purchases would be great to further support the announcement. I don't think I've ever been invested in a company that has had so little staff investment. It's stopped me topping up my holding.

[laughingmike] 31/3/2021 23:02

I've only been a shareholder for a few months, in at 18/19p. I bought in as I was impressed with their pipeline of research and products (loved the bread packaging and airport bags for instance). I found this thread after investing, it has been very informative in highlighting that SYM is always promising but never delivering. To me today's announcements have been very positive but do any of you longer owners/watchers see the latest developments as something different or more of the same?

[gemlotte55] 31/3/2021 22:05

In addition, we continue to advance customer-led trials for our FDA-approved d2p masterbatch for use in bread packaging. This has been an 8-year R&D program which we believe will result in commercial sales this year. This FDA approved d2p technology is proven to keep the inner surface of the packaging free of bacteria that would otherwise contaminate the bread and affect its quality and shelf-life even if the bread contains preservatives. We believe the market opportunity for this value-added product will add significantly to current sales. It is important to add, that our antimicrobial products were confirmed to be effective against coronavirus within one hour of contact.

[gemlotte55] 31/3/2021 21:26

Thought RNS sounded positive for bread wrapping Dave, only thing in RNS that could be negative is the lawyer costs if Eu contests legal challenge.wilk know in 2 weeks.

[dave4545] 31/3/2021 20:35

Imagine though if it announces deals for bread wrapping, shares will go nuts.

Buying all day, even after the shake it was bought back up. Might test 20p tomorrow

[jsforum] 31/3/2021 19:57

Only thing is we are the roast beefs

[dozey3] 31/3/2021 16:05

I like the news this morning. Could be due for damages from EU of multiples of present cap. On the other hand...

[zcaprd7] 31/3/2021 11:47

This lot still not making any money? How many years have they been peddling this stuff?

[dave4545] 31/3/2021 10:04

Pushing on now 18.495p offer

[idriveajag] 31/3/2021 08:52

Good products for the environment and food hygiene. Should thrive.

[dave4545] 31/3/2021 08:37

Strong online 17-17.5p

17.15p bid no quote to buy

Could be heading higher

[gemlotte55] 31/3/2021 08:35

Looking ahead, the firm said the year had started well with the £0.7mln in revenues that missed the year-end cut off date accounted for in the initial months of 2020, a 16% increase on the year-ago period.

Symphony also said customer-led trials for its d2p masterbatch for use in bread packaging are expected to complete in the coming months and the firm believed this will result in “long term material commercial sales later this year”.

“The commercial team is extremely busy and due to strong interest in our technologies, they are focusing on a number of major markets, where sales visibility, potentially high sales volumes, and short-term delivery prospects are strong”, Symphony chief executive Michael Laurier said in a statement.

[dave4545] 31/3/2021 08:34

£1.5 mil unused facility with HSBC

[jmf69] 31/3/2021 08:28

Net cash of 470k at yearend. How long will that last especially when including the legal costs.Another cash raise on the cards. Gla.

[bad gateway] 30/3/2021 21:28

Agreed just saying it would be nice but then as you say a few sales would be nice too.

[dave4545] 30/3/2021 11:25

Been some right lumpy buys.

Every delayed trade is a buy.

When it was weak at 16-17p and some traders selling 10,000 lots at 16p somebody bought 100k at 16.25p then another 100k at 16.4p right after.

Plenty of £10k ish buys too

16.7p to buy now, I think it might break 17p this afternoon and push on